FY23-72066723APS00001: Support for Locally-led Development Approaches Annual Program Statement
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Sudan USAID-Khartoum notices from 2023.
Sudan USAID-Khartoum offered grants of up to $30.0 million to any type of organization. It expected to make about 5 awards worth $7.5 million in total. It is no longer open on Grants.gov.
From the official notice on Grants.gov, last changed May 3, 2023. Checked November 7, 2026.
- Award ceiling$30.0 million
- Total funding$7.5 million
- Expected awards5
- Cost sharingRequired
- Funding typeCooperative Agreement, Grant, Other
Key dates
| Posted | March 16, 2023 |
|---|---|
| Archived by Grants.gov | March 19, 2024 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
See Section C "Eligibility Information" of the APS for detailed information
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $30.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
Updated on 5/3/2023, USAID/Sudan would like to inform the potential Applicants regarding the suspension of the Annual Program Statement (APS) Number: 72066723APS00001 “Support to Locally-led Development Approaches - USAID/Sudan” considering the ongoing security conditions in Sudan. The call for Concept Papers, for the following Addenda, under the APS has been suspended until further notice. USAID/Sudan will continue to evaluate options for programming and will update the status of the APS as soon as possible. Addendum 1 - Local Capacity Strengthening Addendum 2 - Democracy and Governance Addendum 3 - Agriculture and Food Security Addendum 4 - Maternal, Newborn, and Child Health We understand the challenges this poses to applicants and thank you for your interest. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ The United States Agency for International Development (USAID) is announcing the Support for Locally-led Development Approaches Annual Program Statement (APS). Through the Support for Locally-led Development Approaches APS, USAID aims to obtain Concept Papers, request Full Applications, and issue awards to: increase access to comprehensive health services and high-impact interventions to reduce the key drivers of maternal and newborn morbidity and mortality; build climate resilient food systems; and strengthen the capacity of local organizations to implement locally valued and sustainable development outcomes. The purpose of this APS is to disseminate information to prospective Applicants so they may develop and submit Concept Papers in response to future Addenda under this APS and ultimately to be considered for USAID funding. The Addenda will be posted as an amendment to this APS. The deadline for questions, submission instructions and further information will be provided in the respective Addenda.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is FY23-72066723APS00001 still open?
No. It is no longer open on Grants.gov.
Who can apply for Support for Locally-led Development Approaches Annual Program Statement?
Sudan USAID-Khartoum accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Support for Locally-led Development Approaches Annual Program Statement?
Closed. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $30.0 million each. About $7.5 million in total across about 5 awards.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)